Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)

Publication | Closed Access

DOI

184

Citations

References

2019

Year

David R. Spigel, Michael McCleod, Robert M. Jotte, Lawrence H. Einhorn, Leora Horn, David Waterhouse, Ben Creelan, Sunil Babu, Natasha B. Leighl, Jason C. Chandler,

Journal of Thoracic Oncology

Checkmate 153OncologyCancer ManagementOutcomes ResearchPatient-reported OutcomePatient-reported Health-related QualityPoor Performance StatusCancer TreatmentMedicineRadiation OncologyLung Cancer